journal article·2026-04Open access

Self-passivated bilayer black phosphorus QDs based multifunctional nanoparticles for tumor immune reprogramming

Tingting Liu, Wenyan She, Ruili Du, Yali Bao, Zhibin Guo, Qichao Gao, Hanping Li, Pengfei Suo, Yi Liu, Yujiao Liu

Abstract

It is important yet challenging to enhance immunotherapy responses using biosafe agents due to the immunosuppressive tumor microenvironment. To address this challenge, BD3PP was constructed by encapsulating black phosphorus quantum dots (BPQDs), a synthesized thioredoxin reductase inhibitor 3c, and Dir (the fluorescent dye) into PLGA nanoparticles, followed by conjugation with a PDL1 antagonist for synergistic multimodal therapy and imaging. The mechanism and efficiency of BD3PP were investigated through density functional theory (DFT) calculations, molecular docking, and in vitro and in vivo experiments. The PDL1 antagonist served as a targeting moiety that binds PDL1 on the tumor cell surface, enabling the controlled intracellular release of the three therapeutic agents. Self-passivated bilayer BPQDs converted optical energy into heat for photothermal therapy and generated singlet oxygen ( 1 O 2 ) from O 2 for type Ⅱ photodynamic therapy, showing far superior to non-passivated bilayer BPQDs or bulk BP. Meanwhile, 3c selectively inhibited thioredoxin reductase, leading to the production of · and H 2 O 2 . These effects synergistically induced immunogenic cell death (ICD), promoted macrophage polarization toward the M1 phenotype, and remodeled the tumor microenvironment to facilitate tumor clearance. The near-infrared fluorescent dye Dir enabled real-time imaging both in vitro and in vivo . DFT calculation revealed that BPQDs were ultimately degraded into biocompatible phosphoric acid. Along with the other biocompatible components in BD3PP, biosafety was guaranteed. This research introduces an efficient and biosafe nanoplatform based on self-passivated bilayer BPQDs, which exhibits prolonged blood circulation and enhanced multimodal real-time photothermal and near-infrared imaging. Importantly, this nanoplatform enables integrated photothermal, photodynamic, and targeted therapies, demonstrating promising potential for anti-tumor preclinical and clinical applications. • Ultrasmall, homogeneous, self-passivated bilayer BPQDs were successfully prepared. • The PDT mechanism and the biodegradation of BPQDs were firstly investigated by DFT. • BD3PP induced ICD to remodel the tumor microenvironment to clear tumors. • BD3PP prolonged blood circulation, multimode imaging and therapy efficiency.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Carbon and Quantum Dots Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Combination strategies to maximize the benefits of cancer immunotherapy10.1186/s13045-021-01164-5 ↗
2. Biodegradable Cu-based sonozymes for tumor-specific cuproptosis-enhanced sono-immunotherapy through activating cGAS-STING pathway and sensitizing immune checkpoint blockade
3. Responsive biomaterials: optimizing control of cancer immunotherapy10.1038/s41578-023-00617-2 ↗
4. A select inhibitor of MORC2 encapsulated by chimeric membrane-coated DNA nanocage target alleviation TNBC progression
5. Advances in immunotherapy for triple-negative breast cancer10.1186/s12943-023-01850-7 ↗
6. Clinical implications of T cell exhaustion for cancer immunotherapy10.1038/s41571-022-00689-z ↗
7. Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers10.3389/fonc.2020.566511 ↗
8. NIR-II fluorescence and magnetic resonance imaging-guided efficient piezodynamic therapy of subcutaneous glioblastoma with a biomimetic nanoplatform containing defect-engineered piezoelectric shell and downconversion nanocore10.1002/smll.202510697 ↗
9. The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL610.1158/1078-0432.CCR-17-1283 ↗
10. Targeting tumor-associated macrophages to synergize tumor immunotherapy10.1038/s41392-021-00484-9 ↗
11. Engineered macrophages acting as a trigger to induce inflammation only in tumor tissues10.1016/j.jconrel.2023.04.010 ↗
12. Multifunctional mesoporous polydopamine-based systematic delivery of STING agonist for enhanced synergistic photothermal-immunotherapy
13. Injectable tert-butylphenylacetic acid/acrylated β-cyclodextrin-based hydrogels for co-delivery of CAR-T cells and IL-15 in solid tumor therapy
14. Self-enriching nanozyme with photothermal-cascade amplification for tumor microenvironment-responsive synergistic therapy and enhanced photoacoustic imaging
15. Matrix-bound nanovesicles isolated from decellularized tumors as platforms for targeting parent tumor cells and tumor-associated stromal cells
16. Phosphorus-32 microspheres: a dual-modality transarterial radioembolization approach for hepatocellular carcinoma therapy and Anti-PD1 immunotherapy potentiation
17. Rational combination of cancer therapies with PD1 axis blockade10.1038/s41568-024-00727-1 ↗
18. Enhancing tumor immunotherapy by multivalent anti-PD-L1 nanobody assembled via ferritin nanocage
19. Glutathione-responsive metal-organic-framework-derived MnxOy/(A/R) TiO2 nanoparticles for enhanced synergistic sonodynamic/chemodynamic/immunotherapy10.1021/acsnano.4c12304 ↗
20. Engineering of exosome-liposome hybrid-based theranostic nanomedicines for NIR-II fluorescence imaging-guided and targeted NIR-II photothermal therapy of subcutaneous glioblastoma10.1016/j.colsurfb.2024.114258 ↗
21. Bright NIR-II emissive cyanine dye-loaded lipoprotein-mimicking nanoparticles for fluorescence imaging-guided and targeted NIR-II photothermal therapy of subcutaneous glioblastoma10.1186/s12951-024-03074-3 ↗
22. Multifunctional biodegradable nanoplatform based on oxaliplatin prodrug cross-linked mesoporous polydopamine for enhancing cancer synergetic therapy
23. Tumor diagnosis and therapy mediated by metal phosphorus-based nanomaterials10.1002/adma.202103936 ↗
24. Metabolic reprogramming of NK cells by black phosphorus quantum dots potentiates cancer immunotherapy
25. Ultrathin black phosphorus nanosheets for efficient singlet oxygen generation10.1021/jacs.5b06025 ↗
26. ROS-mediated selective killing effect of black phosphorus: mechanistic understanding and its guidance for safe biomedical applications10.1021/acs.nanolett.0c01098 ↗
27. Edge reconstructions of black phosphorene: a global search10.1039/D0NR08505G ↗
28. Atomically sharp, closed bilayer phosphorene edges by self-passivation10.1021/acsnano.2c05014 ↗
29. Application of TD-DFT theory to studying porphyrinoid-based photosensitizers for photodynamic therapy: a review10.3390/molecules26237176 ↗
30. Tunable multi-responsive n-heterocyclic carbene-gold nanoenzyme for tumor-specific pyroptosis and immune activation in cancer therapy10.1016/j.nantod.2024.102537 ↗
31. Blocking of the PD-1/PD-L1 interaction by a d-peptide antagonist for cancer immunotherapy10.1002/anie.201506225 ↗
32. Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase10.1038/s41565-021-00952-x ↗
33. Hallmarks of cancer: the next generation10.1016/j.cell.2011.02.013 ↗
34. The influence of cell cycle regulation on chemotherapy10.3390/ijms22136923 ↗
35. Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform10.2217/pgs.09.154 ↗
36. Complete ablation of resistant tumors with photosensitive black phosphorus quantum dots-based lipid nanocapsules10.1016/j.cej.2020.127879 ↗
37. Black phosphorus nanosheets as a robust delivery platform for cancer theranostics10.1002/adma.201603276 ↗
38. Pyroptosis-inducing self-adaptor to potentiate immune checkpoint blockade therapy for breast cancer by reeducating the treatment-recruited macrophages10.1002/adfm.202414847 ↗
39. Nano-armed limosilactobacillus reuteri for enhanced photo-immunotherapy and microbiota tryptophan metabolism against colorectal cancer
40. In situ observation of thiol michael addition to a reversible covalent drug in a crystalline sponge10.1002/anie.201512038 ↗
41. Engineered biomimetic cancer cell membrane nanosystems trigger gas-immunometabolic therapy for spinal-metastasized tumors
42. Zinc oxide nanoparticles: synthesis, antiseptic activity and toxicity mechanism10.1016/j.cis.2017.07.033 ↗
43. Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer10.1016/j.jconrel.2023.12.022 ↗
44. The ORCA program system10.1002/wcms.81 ↗
45. The ORCA quantum chemistry program package10.1063/5.0004608 ↗
46. Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields10.1021/j100096a001 ↗
47. Effect of the damping function in dispersion corrected density functional theory10.1002/jcc.21759 ↗
48. Fully optimized contracted gaussian basis sets of triple zeta valence quality for atoms Li to Kr10.1063/1.467146 ↗
49. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
50. A comprehensive electron wavefunction analysis toolbox for chemists, Multiwfn10.1063/5.0216272 ↗